Musings on fundraising in 2025Why regime matters when raising capital.Feb 5A response icon1Feb 5A response icon1
Published inStoic VCWhy we invested in Neurode.Stoic VC memo on Neurode’s $3.5M US Pre-seedOct 6, 2024Oct 6, 2024
Published inStoic VCWhy we doubled down on Kinoxis.Stoic VC memo on Kinoxis Therapeutics Pty Ltd $14.5M Series BSep 1, 2024Sep 1, 2024
State of venture markets in 2023My key observations on deep tech venture capital this yearDec 24, 2023Dec 24, 2023
Published inStoic VCStoic’s Year in review 20232023 has been another big year at Stoic. We first provide commentary on the venture market this year. We then dig into what we’ve been up…Dec 22, 2023Dec 22, 2023
